生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Ac-DEVD-CHO is a highly potent peptide-base Group II caspase inhibitor, most potent to caspase 3 and caspase 8 with Ki value of 230pM and 920pM, respectively, and modest to caspase1/7/10/6/9 with Ki values of 18/1.6/12/31/60nM, and less potent to caspase 4/5/2 with Ki values of 132/205/1710nM[1][2]. Ac-DEVD-CHO could inhibit the PARP cleavage activity in apoptotic osteosarcoma cells extract with IC50 of 0.2nM[2]. Inhibition of caspase 3 through intraperitoneal injection with Ac-DEVD-CHO at dose of 3mg/kg for 3 days resulted in a reduction of activated caspase-3 by 61% and reduction of apoptosis by 84% in cardiomyocytes in young mice[3]. | ||
作用机制 | DEVD is the canonical peptide sequence which can be recognized by Caspase-3 and caspase-7.[4] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.99mL 0.40mL 0.20mL |
9.95mL 1.99mL 1.00mL |
19.90mL 3.98mL 1.99mL |
参考文献 |
---|